For example, in tumor cell therapy, the type III Fc-gamma receptor (FcγR), also known as CD16, on NK cells recognizes the Fc portion of antibodies bound to tumor cells and triggers the cell death of tumor cells through ADCC. The gene discussed is FCGR2A; the disease is neoplasm.